These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
103 related items for PubMed ID: 15007915
1. [Therapeutic drug monitoring of cyclosporine MEPC (Neoral) therapy for interstitial pneumonia]. Inoue T, Tanaka E, Kato T, Sakuramoto M, Minakuchi M, Maeda Y, Maniwa K, Terada K, Taguchi Y. Nihon Kokyuki Gakkai Zasshi; 2004 Feb; 42(2):153-7. PubMed ID: 15007915 [Abstract] [Full Text] [Related]
3. Suitable whole blood levels 2 hours after neoral in liver transplant patients: experiences at a single center. Kim KH, Lee SG, Lee YJ, Park KM, Hwang S, Ahn CS, Moon DB, Ha TY, Song KW, Kim DS, Jung DH, Kim BS, Moon KM, Lee HJ, Park JI, Ryu JH. Transplant Proc; 2006 Nov; 38(9):2971-3. PubMed ID: 17112877 [Abstract] [Full Text] [Related]
4. Pharmacokinetics of oral cyclosporine (Neoral) in heart transplant recipients during the immediate period after surgery. Banner NR, David OJ, Leaver N, Davis J, Breen J, Johnston A, Yacoub MH. Transpl Int; 2002 Dec; 15(12):649-54. PubMed ID: 12478413 [Abstract] [Full Text] [Related]
5. Neoral monitoring by simplified sparse sampling area under the concentration-time curve: its relationship to acute rejection and cyclosporine nephrotoxicity early after kidney transplantation. Mahalati K, Belitsky P, Sketris I, West K, Panek R. Transplantation; 1999 Jul 15; 68(1):55-62. PubMed ID: 10428267 [Abstract] [Full Text] [Related]
6. Effect of diltiazem on the pharmacokinetics of microemulsion cyclosporine A in renal transplantation. Bunnag S, Vareesangthip K, Ong-ajyooth L. J Med Assoc Thai; 2006 Aug 15; 89 Suppl 2():S228-34. PubMed ID: 17044476 [Abstract] [Full Text] [Related]
9. Impact of late conversion from C0 to C2 monitoring of microemulsified cyclosporine in pediatric living donor liver transplant recipients. Takatsuki M, Chen CL, Chen YS, Wang CC, Lin CC, Yang CH, Yong CC, Liu YW. Clin Transplant; 2004 Dec 15; 18(6):694-9. PubMed ID: 15516246 [Abstract] [Full Text] [Related]
11. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens. Dösch AO, Ehlermann P, Koch A, Remppis A, Katus HA, Dengler TJ. Clin Ther; 2006 Jun 15; 28(6):893-905. PubMed ID: 16860172 [Abstract] [Full Text] [Related]
14. Evolution of the therapeutic drug monitoring of cyclosporine. Citterio F. Transplant Proc; 2004 Mar 15; 36(2 Suppl):420S-425S. PubMed ID: 15041378 [Abstract] [Full Text] [Related]
15. Cyclosporine C2 monitoring is superior to C0 in predicting acute cellular rejection in heart transplant recipients in Taiwan. Chou NK, Chen RJ, Ko WJ, Lin HL, Yu SY, Chen YS, Hsu RB, Lee CM, Lin FY, Wang SS. Transplant Proc; 2004 Oct 15; 36(8):2393-5. PubMed ID: 15561260 [Abstract] [Full Text] [Related]
19. Early intervention with corticosteroids and cyclosporin A and 2-hour postdose blood concentration monitoring improves the prognosis of acute/subacute interstitial pneumonia in dermatomyositis. Kotani T, Makino S, Takeuchi T, Kagitani M, Shoda T, Hata A, Tabushi Y, Hanafusa T. J Rheumatol; 2008 Feb 15; 35(2):254-9. PubMed ID: 18085732 [Abstract] [Full Text] [Related]
20. Monitoring treatment with cyclosporine microemulsion in myasthenia gravis. Utsugisawa K, Nagane Y, Suzuki S, Suzuki N. Eur J Neurol; 2008 Jun 15; 15(6):598-604. PubMed ID: 18410372 [Abstract] [Full Text] [Related] Page: [Next] [New Search]